Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-129017
Filing Date
2023-12-26
Accepted
2023-12-26 09:28:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2333635d1_424b5.htm 424B5 413801
2 GRAPHIC tm2333635d1_424b5-img01.jpg GRAPHIC 3668
  Complete submission text file 0001104659-23-129017.txt   420172
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-274328 | Film No.: 231511484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)